These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 22097216

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule].
    Sun W, Li CQ, Chen JH, Shao JD, Zhou D, Zhang L, Gao K.
    Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):81-90. PubMed ID: 23596882
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model.
    Terai K, Mizukami K, Okada M.
    Nephrology (Carlton); 2008 Apr; 13(2):139-46. PubMed ID: 18275502
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Astilbin attenuates hyperuricemia and ameliorates nephropathy in fructose-induced hyperuricemic rats.
    Chen L, Lan Z, Zhou Y, Li F, Zhang X, Zhang C, Yang Z, Li P.
    Planta Med; 2011 Nov; 77(16):1769-73. PubMed ID: 21614752
    [Abstract] [Full Text] [Related]

  • 47. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.
    Nagano N, Miyata S, Obana S, Kobayashi N, Fukushima N, Burke SK, Wada M.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2014-23. PubMed ID: 13679475
    [Abstract] [Full Text] [Related]

  • 48. [Evaluation of dialysis in patients with end-stage renal disease by salivary urea, creatinine and uric acid].
    Cheng P, Xia Y, Peng C, Zhou Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 38(12):1260-3. PubMed ID: 24384951
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Effects of protease therapy in the remnant kidney model of progressive renal failure.
    Sebekova K, Paczek L, Dämmrich J, Ling H, Spustova V, Gaciong Z, Heidland A.
    Miner Electrolyte Metab; 1997 Dec; 23(3-6):291-5. PubMed ID: 9387136
    [Abstract] [Full Text] [Related]

  • 53. [Experimental study in treating chronic renal failure with dry extract and tannins of herba ephedra].
    Wang GZ, Hikokichi O.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Aug; 14(8):485-8. PubMed ID: 7841758
    [Abstract] [Full Text] [Related]

  • 54. Chronic lead accumulation as a possible cause of renal failure in gouty patients.
    Colleoni N, D'Amico G.
    Nephron; 1986 Aug; 44(1):32-5. PubMed ID: 3092121
    [Abstract] [Full Text] [Related]

  • 55. [Researches on the establishment of chronic nephropathy models and the effect of TCM on these models].
    Gao ZQ, Deng YY, Wang L, Chen YP.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Feb; 25(2):186-9. PubMed ID: 15768889
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Familial gout and renal failure.
    Warren DJ, Simmonds HA, Gibson T, Naik RB.
    Arch Dis Child; 1981 Sep; 56(9):699-704. PubMed ID: 7294873
    [Abstract] [Full Text] [Related]

  • 58. Requiem for gouty nephropathy.
    Beck LH.
    Kidney Int; 1986 Aug; 30(2):280-7. PubMed ID: 3761864
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Non-oliguric acute renal failure in gout.
    Patial RK, Sehgal VK.
    Indian J Med Sci; 1992 Jul; 46(7):201-4. PubMed ID: 1398813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.